209 related articles for article (PubMed ID: 377957)
1. The biochemical genetics of the hexosaminidase system in man.
Beutler E
Am J Hum Genet; 1979 Mar; 31(2):95-105. PubMed ID: 377957
[TBL] [Abstract][Full Text] [Related]
2. The expression of hex A and hex B isozymes of hexosaminidase in parental and experimental human fibroblast cells and their components.
Bladon MT
Biochem Genet; 1981 Oct; 19(9-10):971-86. PubMed ID: 7332532
[TBL] [Abstract][Full Text] [Related]
3. The mutation mechanism causing juvenile-onset Tay-Sachs disease among Lebanese.
Hechtman P; Boulay B; Bayleran J; Andermann E
Clin Genet; 1989 May; 35(5):364-75. PubMed ID: 2527097
[TBL] [Abstract][Full Text] [Related]
4. A new form of residual hexosaminidase activity in infantile Tay Sachs disease fibroblasts.
Hechtman P; Khoo K; Isaacs C
Clin Genet; 1983 Sep; 24(3):206-15. PubMed ID: 6226462
[TBL] [Abstract][Full Text] [Related]
5. The lysosomal hexosaminidase isozymes.
Mahuran D; Novak A; Lowden JA
Isozymes Curr Top Biol Med Res; 1985; 12():229-88. PubMed ID: 3886595
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure of human beta-hexosaminidase B: understanding the molecular basis of Sandhoff and Tay-Sachs disease.
Mark BL; Mahuran DJ; Cherney MM; Zhao D; Knapp S; James MN
J Mol Biol; 2003 Apr; 327(5):1093-109. PubMed ID: 12662933
[TBL] [Abstract][Full Text] [Related]
7. Juvenile GM2 gangliosidosis (AMB variant): inability to activate hexosaminidase A by activator protein.
Inui K; Grebner EE; Jackson LG; Wenger DA
Am J Hum Genet; 1983 Jul; 35(4):551-64. PubMed ID: 6224417
[TBL] [Abstract][Full Text] [Related]
8. Hereditary heat-labile hexosaminidase B: a variant whose homozygotes synthesize a functional HEX A.
Navon R; Kopel R; Nutman J; Frisch A; Conzelmann E; Sandhoff K; Adam A
Am J Hum Genet; 1985 Jan; 37(1):138-46. PubMed ID: 3156493
[TBL] [Abstract][Full Text] [Related]
9. Hexosaminidase isozyme in type O Gm2 gangliosidosis (Sandhoff-Jatzkewitz disease).
Beutler E; Kuhl W; Comings D
Am J Hum Genet; 1975 Sep; 27(5):628-38. PubMed ID: 808963
[TBL] [Abstract][Full Text] [Related]
10. Evidence for a hybrid hexosaminidase isoenzyme in heterozygotes for Sandhoff disease.
Lowden JA
Am J Hum Genet; 1979 May; 31(3):281-9. PubMed ID: 463876
[TBL] [Abstract][Full Text] [Related]
11. [Genetic study of GM2 gangliosidosis (Tay-Sachs and Sandhoff) by the study of the hexosaminidases of the Sandhoff-rodents hybrids (mouse and hamster)].
Weil D; Van Cong N; Rebourcet R; Frézal J
Ann Genet; 1975 Sep; 18(3):163-8. PubMed ID: 810067
[TBL] [Abstract][Full Text] [Related]
12. Segregation of Tay-Sachs and Sandhoff alleles in a non-Jewish family.
Lane AB; Young E; Jenkins T
Am J Hum Genet; 1980 Nov; 32(6):920-6. PubMed ID: 7446530
[TBL] [Abstract][Full Text] [Related]
13. [Recent advances in molecular genetics of GM2 gangliosidosis].
Wakamatsu N
Nihon Rinsho; 1995 Dec; 53(12):2988-93. PubMed ID: 8577047
[TBL] [Abstract][Full Text] [Related]
14. Hexosaminidase C in brain affected by Tay-Sachs Disease.
Minami R; Nakamura F; Oyanagi K; Nakao T
Tohoku J Exp Med; 1981 Feb; 133(2):175-85. PubMed ID: 7268761
[TBL] [Abstract][Full Text] [Related]
15. [Reconstruction of hexosaminidase isoenzymes during hybridization of fibroblasts from Tay-Sachs and Sandhoff diseases].
Beĭer EM; Vidershaĭn GIa; Venert M
Biull Eksp Biol Med; 1984 Jan; 97(1):83-6. PubMed ID: 6229294
[TBL] [Abstract][Full Text] [Related]
16. Lyso-GM2 ganglioside: a possible biomarker of Tay-Sachs disease and Sandhoff disease.
Kodama T; Togawa T; Tsukimura T; Kawashima I; Matsuoka K; Kitakaze K; Tsuji D; Itoh K; Ishida Y; Suzuki M; Suzuki T; Sakuraba H
PLoS One; 2011; 6(12):e29074. PubMed ID: 22205997
[TBL] [Abstract][Full Text] [Related]
17. Apoptotic cell death in mouse models of GM2 gangliosidosis and observations on human Tay-Sachs and Sandhoff diseases.
Huang JQ; Trasler JM; Igdoura S; Michaud J; Hanal N; Gravel RA
Hum Mol Genet; 1997 Oct; 6(11):1879-85. PubMed ID: 9302266
[TBL] [Abstract][Full Text] [Related]
18. GM2-ganglioside metabolism in hexosaminidase A deficiency states: determination in situ using labeled GM2 added to fibroblast cultures.
Raghavan SS; Krusell A; Krusell J; Lyerla TA; Kolodny EH
Am J Hum Genet; 1985 Nov; 37(6):1071-82. PubMed ID: 2934978
[TBL] [Abstract][Full Text] [Related]
19. [Molecular pathogenesis and therapeutic approach of GM2 gangliosidosis].
Tsuji D
Yakugaku Zasshi; 2013; 133(2):269-74. PubMed ID: 23370522
[TBL] [Abstract][Full Text] [Related]
20. The specificity of human N-acetyl-beta-D-hexosaminidases towards glycosphincolipids is determined by an activator protein.
Conzelmann E; Sandhoff K
Adv Exp Med Biol; 1980; 125():295-306. PubMed ID: 6444774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
